Patents by Inventor Animesh Goswami

Animesh Goswami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9920090
    Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivaties that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formulas I, II and III: These compounds are useful for the treatment of HIV and AIDS.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: March 20, 2018
    Assignee: ViiV HEALTHCARE UK (NO.5) LIMITED
    Inventors: Alicia Regueiro-Ren, Animesh Goswami, Zhiwei Guo, Thomas P. Tully, Jacob Swidorski, Zheng Liu, Nicholas A. Meanwell
  • Publication number: 20170204133
    Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivaties that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formulas I, II and III: These compounds are useful for the treatment of HIV and AIDS.
    Type: Application
    Filed: June 17, 2015
    Publication date: July 20, 2017
    Inventors: Alicia REGUEIRO-REN, Animesh GOSWAMI, Zhiwei GUO, Thomas P. TULLY, Jacob SWIDORSKI, Zheng LIU, Nicholas A. MEANWELL
  • Patent number: 8828691
    Abstract: The present disclosure provides a method for the stereospecific hydrolysis of racemic 1,1-dialkyloxycarbonylcyclopropanes.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: September 9, 2014
    Assignee: Bristol-Myers Squibb Company
    Inventors: Animesh Goswami, Zhiwei Guo, Yuping Qiu
  • Publication number: 20090298794
    Abstract: The present invention provides compounds having the following Formula IA and IB, which are useful as MCHR1 antagonists, and includes prodrugs and pharmaceutically acceptable salts thereof:
    Type: Application
    Filed: May 28, 2009
    Publication date: December 3, 2009
    Inventors: William N. Washburn, Saleem Ahmad, Pratik Devasthale, Jeffrey A. Robl, Animesh Goswami, Zhiwei Guo, Ramesh N. Patel
  • Patent number: 7393667
    Abstract: The invention relates to a process for the enzymatic, stereoselective reduction of ketone compounds to provide chiral alcohols, for example the compound of formula Ib:
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: July 1, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ramesh N. Patel, Linda Nga Hoong Chu, Robert M. Johnson, Zhiwei Guo, Yijun Chen, Steven L. Goldberg, Ronald L. Hanson, Animesh Goswami, Kishta Katipally
  • Publication number: 20070231858
    Abstract: Disclosed and claimed herein are novel biocatalysts for converting racemic mixtures of amino acids to an enantiomerically pure (S) form of the amino acid, methods for their use, and the enantiomerically enriched products of such biocatalytic processes.
    Type: Application
    Filed: March 23, 2007
    Publication date: October 4, 2007
    Inventors: Ramesh Patel, Yijun Chen, Steven Goldberg, Iqbal Gill, Animesh Goswami, Thomas Tully, William Parker, Ronald Hanson
  • Publication number: 20060286646
    Abstract: The invention relates to a process for the enzymatic, stereoselective reduction of ketone compounds to provide chiral alcohols, for example the compound of formula Ib:
    Type: Application
    Filed: May 31, 2006
    Publication date: December 21, 2006
    Applicant: Bristol-Myers Squibb Company
    Inventors: Ramesh Patel, Linda Chu, Robert Johnson, Zhiwei Guo, Yijun Chen, Steven Goldberg, Ronald Hanson, Animesh Goswami, Kishta Katipally
  • Patent number: 6953679
    Abstract: Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: October 11, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Mark E. Salvati, Toomas Mitt, Ramesh N. Patel, Ronald L. Hanson, David Brzozowski, Animesh Goswami, Linda Nga Hoong Chu, Wen-sen Li, James H. Simpson, Michael J. Totleben, Weixuan He
  • Publication number: 20050119228
    Abstract: Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: December 19, 2001
    Publication date: June 2, 2005
    Inventors: Mark Salvati, Toomas Mitt, Ramesh Patel, Ronald Hanson, David Brzozowski, Animesh Goswami, Linda Chu, Wen-sen Li, James Simpson, Michael Totleben, Weixuan He
  • Patent number: 6800477
    Abstract: The present invention is directed to novel stereoselective processes for the preparation of (S)-1-arylethanols by the reduction of the corresponding keto group containing compounds by microorganisms. (S)-1-arylethanols are useful as intermediates in the synthesis of compounds that are inhibitors of &ggr;-secretase useful in the treatment of Alzheimer's disease.
    Type: Grant
    Filed: March 6, 2002
    Date of Patent: October 5, 2004
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Ramesh Patel, Animesh Goswami, Linda N. Chu, Venkata B. Nanduri, Steven L. Goldberg, Robert M. Johnston, Mary Jo Donovan, K. David Mirfakhrae
  • Publication number: 20030068811
    Abstract: The present invention is directed to novel stereoselective processes for the preparation of (S)-1-arylethanols by the reduction of the corresponding keto group containing compounds by microorganisms. (S)-1-arylethanols are useful as intermediates in the synthesis of compounds that are inhibitors of &ggr;-secretase useful in the treatment of Alzheimer's disease.
    Type: Application
    Filed: March 6, 2002
    Publication date: April 10, 2003
    Inventors: Ramesh Patel, Animesh Goswami, Linda N. Chu, Venkata B. Nanduri, Steven L. Goldberg, Robert M. Johnston, Mary Jo Donovan, K. David Mirfakhrae
  • Patent number: 5997907
    Abstract: Methods for enhancing the stability of thickening agent solutions, especially guar solutions, by sterilizing the solution with UV light and/or adding a surfactant to the solution are disclosed. Thickening agent solutions and powders, including guar solutions and powders, as well as products made from these solutions and powders, are also disclosed.
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: December 7, 1999
    Assignee: Rhodia Inc.
    Inventors: Animesh Goswami, Paul-Joel Derian
  • Patent number: 5801116
    Abstract: A solid composition of matter comprising one or more polysaccharides which has a coarse particle size is provided. The composition demonstrates absorbent properties and is useful in absorbent articles of manufacture. Also provided is a method for preparing the compositions.
    Type: Grant
    Filed: June 20, 1997
    Date of Patent: September 1, 1998
    Assignee: Rhodia Inc.
    Inventors: Ian William Cottrell, Animesh Goswami, Manjit Singh Chowdhary
  • Patent number: 5532350
    Abstract: A solid composition of matter comprising one or more polysaccharides which has been cross-linked with either titanium or zirconium cross-linking agents is provided. The composition demonstrates absorbent properties and is useful in absorbent articles of manufacture. Also provided is a method for preparing the compositions.
    Type: Grant
    Filed: February 15, 1994
    Date of Patent: July 2, 1996
    Assignee: Rhone-Poulenc Inc.
    Inventors: Ian W. Cottrell, Animesh Goswami, Manjit S. Chowdhary
  • Patent number: 5281534
    Abstract: Chrysanthemic acid esters can be geometrically separated into its cis- and trans- isomers as well as resolved into enantiomers by hydrolysis using liver enzymes, particularly from sheep, goat, bovine, dog, chicken, mouse, calf, horse, pigeon, rabbit, cat, whale and rat and particularly horse.
    Type: Grant
    Filed: May 18, 1992
    Date of Patent: January 25, 1994
    Assignee: Rhone-Poulenc Inc.
    Inventor: Animesh Goswami
  • Patent number: 5175100
    Abstract: 2-Arylpropionic acids such as ketoprofen, ibuprofen and naproxen can be stereospecifically resolved from their esters by hydrolysis using liver enzymes and particularly liver acetone powders derived from specific animals such as dog, pigeon, horse and goat.
    Type: Grant
    Filed: June 24, 1991
    Date of Patent: December 29, 1992
    Assignee: Rhone-Poulenc, Inc.
    Inventor: Animesh Goswami
  • Patent number: 5108916
    Abstract: An immobilized isozyme of Lipase MY or AY from Candida rugosa is used for stereoselectively hydrolyzing racemic mixtures of esters of 2-substituted acids, other than 2-halo propionic acids, transesterifying esters or acids or esterify acids or alcohols, at high enantiomeric excess, in an organic solvent. Immobilization of the isozyme may be carried out in the presence of an organic acid such as stearic acid. The immobilized isozyme may be used with a fatty acid or fatty acid ester that increases stereoselectivity or rate of hydrolysis of a mixture of racemic esters.
    Type: Grant
    Filed: June 5, 1989
    Date of Patent: April 28, 1992
    Assignee: Rhone-Poulenc Rorer, S.A.
    Inventors: Carrington S. Cobbs, Michael J. Barton, Lin Peng, Animesh Goswami, Adrien P. Malick, John P. Hamman, Gary J. Calton